Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Álvaro Curiel‐García

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6249-3267; OpenAlex author ID A5078241450. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 3 papers · 2025: none · 2026: 2 papers

Papers 9

  1. Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer. Co-author DOI 10.1038/s41588-026-02714-8↗
  2. eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-25-4299↗
  3. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-07379-z↗
  4. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08084-7↗
  5. Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Co-author DOI 10.1158/2159-8290.cd-23-0240↗
  6. Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biopha.2022.114162↗
  7. Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer Co-author DOI 10.1101/2023.03.19.533333↗
  8. Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices. Co-author DOI 10.1016/j.xpro.2022.101899↗
  9. Modeling Pancreatic Cancer through Somatic Editing with AAV. Co-author DOI 10.1016/j.molmed.2019.02.012↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenneth P. Olive · 6 shared papers, 2019–2026 · strength 1.11
  2. H. Carlo Maurer · 3 shared papers, 2023–2026 · strength 0.50
  3. Andrea Califano · 3 shared papers, 2023–2026 · strength 0.50
  4. Amanda R. Decker-Farrell · 2 shared papers, 2022–2024 · strength 0.39
  5. Urszula N. Wasko · 2 shared papers, 2024–2026 · strength 0.38
  6. Alina Cornelia Iuga · 2 shared papers, 2023–2026 · strength 0.34
  7. Pasquale Laise · 2 shared papers, 2023–2026 · strength 0.34
  8. Gulam Abbas Manji · 2 shared papers, 2023–2026 · strength 0.34
  9. Iok In Christine Chio · 1 shared paper, 2026 · strength 0.28
  10. James M. Powers · 1 shared paper, 2026 · strength 0.28
  11. Ela Elyada · 1 shared paper, 2026 · strength 0.21
  12. Sabrina Ge · 1 shared paper, 2026 · strength 0.21
  13. Faiyaz Notta · 1 shared paper, 2026 · strength 0.21
  14. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
  15. Sladjana Zagorac · 1 shared paper, 2023 · strength 0.18
  16. Sarah Courtois · 1 shared paper, 2023 · strength 0.18
  17. Patricia Sancho · 1 shared paper, 2023 · strength 0.18
  18. Beatriz Parejo-Alonso · 1 shared paper, 2023 · strength 0.18
  19. Pilar Espiau-Romera · 1 shared paper, 2023 · strength 0.18
  20. Christopher Heeschen · 1 shared paper, 2023 · strength 0.18
  21. Alexander Muir · 1 shared paper, 2024 · strength 0.17
  22. Ezequiel J. Tolosa · 1 shared paper, 2024 · strength 0.17
  23. Marie C. Hasselluhn · 1 shared paper, 2024 · strength 0.17
  24. Martín E. Fernández-Zapico · 1 shared paper, 2024 · strength 0.17
  25. Michael A. Badgley · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.